Carolinas Wealth Consulting’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-12
| Closed | -$3.7K | – | 895 |
|
|
2025
Q1 | $3.7K | Hold |
12
| – | – | ﹤0.01% | 659 |
|
|
2024
Q4 | $4.24K | Hold |
12
| – | – | ﹤0.01% | 669 |
|
|
2024
Q3 | $4.3K | Hold |
12
| – | – | ﹤0.01% | 687 |
|
|
2024
Q2 | $3.82K | Sell |
12
-6
| -33% | -$1.91K | ﹤0.01% | 692 |
|
|
2024
Q1 | $4.14K | Hold |
18
| – | – | ﹤0.01% | 671 |
|
|
2023
Q4 | $3.96K | Hold |
18
| – | – | ﹤0.01% | 654 |
|
|
2023
Q3 | $4.01K | Sell |
18
-25
| -58% | -$5.57K | ﹤0.01% | 642 |
|
|
2023
Q2 | $9.49K | Sell |
43
-17
| -28% | -$3.75K | ﹤0.01% | 597 |
|
|
2023
Q1 | $13.4K | Hold |
60
| – | – | ﹤0.01% | 558 |
|
|
2022
Q4 | $16.7K | Sell |
60
-13
| -18% | -$3.62K | ﹤0.01% | 531 |
|
|
2022
Q3 | $15K | Hold |
73
| – | – | ﹤0.01% | 502 |
|
|
2022
Q2 | $17K | Hold |
73
| – | – | ﹤0.01% | 484 |
|
|
2022
Q1 | $13K | Hold |
73
| – | – | ﹤0.01% | 568 |
|
|
2021
Q4 | $16K | Sell |
73
-8
| -10% | -$1.75K | ﹤0.01% | 543 |
|
|
2021
Q3 | $15K | Hold |
81
| – | – | ﹤0.01% | 528 |
|
|
2021
Q2 | $15K | Sell |
81
-226
| -74% | -$41.9K | ﹤0.01% | 555 |
|
|
2021
Q1 | $51K | Sell |
307
-11
| -3% | -$1.83K | 0.01% | 356 |
|
|
2020
Q4 | $48K | Buy |
318
+225
| +242% | +$34K | 0.01% | 350 |
|
|
2020
Q3 | $9K | Buy |
+93
| New | +$9K | ﹤0.01% | 503 |
|